EU Frontier AI Initiative: Advanced Scaling Frameworks for High-Performance AI Models (RIA) - Apply AI
Issued by European Commission · via EU Funding & Tenders Portal
- Published
- 9 Oct 2026
- Closes
- 16 Feb 2027
- Reference
- HORIZON-BRIDGING-2027-01-13
- Location
- European Union
- Sector
- Healthcare & Pharma
At a glance
European Commission in European Union has published a funding call in healthcare & pharma: “EU Frontier AI Initiative: Advanced Scaling Frameworks for High-Performance AI Models (RIA) - Apply AI”. Submissions close on 16 February 2027, 130 days from today. Quote reference HORIZON-BRIDGING-2027-01-13 in any correspondence with the buyer. FreeTender has recorded 361 notices from this buyer since 2026, 358 of them currently open. There are 32 open healthcare & pharma notices in European Union on FreeTender. Bids are submitted to the buyer through EU Funding & Tenders Portal, not through FreeTender.
Details
Expected Outcome:
This topic aims to advance the scientific and technical foundations for the scaling of AI models, enhancing the performance of training and inference processes and providing European AI labs with the methodologies required to compete at the global frontier. Project results are expected to contribute to some of the following outcomes:
- Establishment of robust scaling laws and predictive frameworks that allow for the reliable estimation of model performance before large-scale compute investment.
- Enhanced competitiveness of European advanced AI models through optimised dataset mixtures, refined architectures, and superior hyperparameter configurations.
- Optimised development for frontier AI models, achieved via automated and scientifically grounded scaling methodologies.
Scope:
To maintain a leading position in AI, Europe must master the methodologies required to scale AI models’ performance, training and inference processes. Establishing a predictive methodology for AI model development ensures that limited computational resources are deployed with maximum efficiency, thereby bolstering the EU and AC’s technological sovereignty. While previous actions have focused on training High-Performance AI models, this topic addresses the research gap in the underlying theoretical basis, methodologies and tools for predictable scaling of AI models and inference. By providing the technical foundations for high-performance systems without the costs of unguided experimentation, this action complements training-centric efforts. In this light, proposals should deliver, as an outcome of the research, a toolset designed to support the scaling of AI models. Potential research areas include, but are not limited to:
- Automated Scaling Law Derivation: Research into scaling laws to predict performance across diverse modalities and tasks, moving beyond simple power laws.
- Exploratory Architecture Search: Developing automated methods to discover and refine model architectures that maintain performance while scaling both in training and inference, including innovations in sparsity, memory efficiency, and long-context handling.
- Dataset Mixture Optimisation: Research into the systematic selection, weighting, and sequencing of datasets. This includes developing tools for automated data quality assessment.
- Advanced Hyperparameter Tuning and Stability: Developing methodologies for stable training at large scales, including automated tuning of optimisers and learning rate schedules that remain effective as models grow.
Proposals should ensure that the developed frameworks and scaling methodologies are compatible with diverse hardware architectures, demonstrating that scaling is studied across different systems to avoid optimisation for specific proprietary hardware. The selected project should actively support Advanced AI labs and High-performance Computing Centres already engaged in the development of frontier AI, ensuring that methodological advances are immediately validated in high-stakes environments. Proposals should describe how these scaling methodologies would benefit the development of models adapted to the specific requirements of particular strategic sectors, such as Public Administration, Manufacturing, Energy, Healthcare, Cultural and Creative Industries, or Physical AI. Part of the Frontier AI Initiative, this topic complements HORIZON-CL4-2027-04-DIGITAL-EMERGING-11 “EU Frontier AI Initiative: Developing frontier AI solutions that are safe and computationally efficient within Apply AI” by establishing the underlying methodologies required for the large-scale training and inference of High-Performance AI models. Proposals should, therefore, describe the link between their planned activities and the objectives of topic HORIZON-CL4-2027-04-DIGITAL-EMERGING-11. All proposals are expected to incorporate mechanisms for assessing and demonstrating progress, including qualitative and quantitative KPIs, benchmarking, and progress monitoring. When possible, proposals should build on and reuse public results from relevant previous funded actions. Communicable results should be shared with the European R&D community through the AI-on-demand platform. The project selected in this topic should link to the resources offered by the AI Factories and the Data Labs. Where relevant, links could be established to European companies developing frontier AI models to foster a pre-competitive exchange of expertise and explore ways to mobilise the wider developer community for the efficient reuse of results. All proposals are expected to allocate tasks for cohesion activities with the European Partnership on AI, data, and robotics (ADRA) and the CSA HORIZON-CL4-2025-03-HUMAN-18: GenAI4EU central Hub. Technology Readiness Level - Technology readiness level expected from completed projects Activities are expected to achieve TRL 4-5 by the end of the project – see General Annex B.
Submissions open on 20 October 2026.
Part of call HORIZON-BRIDGING-2027-01
Type of action: HORIZON Research and Innovation Actions
Programme period: 2021 - 2027
Priorities: DigitalAgenda, AI
"> General conditions
1. Admissibility conditions: Proposal page limit and layout
described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries
described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide .
3. Other Eligibility Conditions
In order to achieve the expected outcomes, and safeguard the Union’s strategic assets, interests, autonomy, and security, it is important to avoid a situation of technological dependency on a non-EU source, in a global context that requires the EU to take action to build on its strengths, and to carefully assess and address any strategic weaknesses, vulnerabilities and high-risk dependencies which put at risk the attainment of its ambitions. For this reason, participation is limited to legal entities established in Member States, Iceland and Norway and the following additional associated countries : Canada, Israel, Republic of Korea, New-Zealand, United Kingdom, Switzerland and Japan. In addition, entities established in third countries which may become associated to Horizon Europe during 2026 and 2027 may be eligible
Context for bidders
We hold 361 notices from European Commission, going back to August 2026 — 358 of them still open. They buy mostly in Water & Environment, Forestry & Wildlife and IT & Telecom. There are 32 open Healthcare & Pharma tenders in European Union. This one closes in 130 days.
More from this buyer
- Sustainable and Competitive Cell Production Techniques for Lithium-ion And Sodium-ion Batteries (BATT4EU Partnership)· closes 31 Mar
- Open topic: Innovative solutions for the European Water Resilience Strategy· closes 8 Apr
- Open grounds for future pre-commercial procurement of innovative security technologies· closes 4 Nov
- Development of innovative antimicrobials against pathogens resistant to antimicrobials· closes 17 Feb
- ‘Proof of market’ to improve valorisation and commercialisation of Horizon generated R&I results (IA)· closes 2 Feb
Similar Healthcare & Pharma tenders
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential· closes 17 Feb
- Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases· closes 17 Feb
- Addressing disabilities through the life course to support independent living and inclusion· closes 17 Feb
- Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis· closes 16 Sept
- Advancing bio-printing of living cells for regenerative medicine· closes 16 Sept
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- О проведении государственной закупки товара для НАО «Казахский национальный медицинский университет имени С. Д. Асфендиярова» способом открытого конкурса — Аппарат искусственного кровообращенияНекоммерческое акционерное общество "Казахский национальный медицинский университет имени С. Д. Асфендиярова" · Kazakhstan
- Public notice regarding procurement of reagents for hematology analyzer at Dr Hedgewar Arogya SansthanHealth & Family Welfare Department, Govt. of NCT of Delhi · India
- Изделия медицинского назначенияРеспубликанское государственное предприятие "Больница Медицинского центра Управления Делами Президента Республики Казахстан" на праве хозяйственного ведения · Kazakhstan
- Приобретение изделий медицинского назначения (в том числе в операционный блок )ГУ "Региональный военный госпиталь c поликлиникой Комитета национальной безопасности Республики Казахстан в городе Актау (секретно)" · Kazakhstan
- Приобретение лекарственных средствГУ "Региональный военный госпиталь c поликлиникой Комитета национальной безопасности Республики Казахстан в городе Актау (секретно)" · Kazakhstan
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →